An announcement from Senti Biosciences ( (SNTI) ) is now available.
On March 7, 2025, Senti Biosciences, Inc. expanded its Board of Directors by appointing Feng Hsiung as a Class III director, increasing the number of board members from six to seven. Mr. Hsiung, with a rich background in business, finance, and investment, is expected to serve until the 2028 annual stockholders meeting, subject to election in 2025. Additionally, the company amended its 2022 Inducement Plan, adding 500,000 shares for new employee inducements, and revised its Non-Employee Director Compensation Policy to attract and retain qualified board members. The changes reflect Senti Biosciences’ strategic efforts to strengthen its governance and incentivize new talent.
More about Senti Biosciences
YTD Price Performance: -7.61%
Average Trading Volume: 80,071
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $17M
For a thorough assessment of SNTI stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com